Dr. Arthur Mutyaba

Arthur Mutyaba is a cardiovascular researcher based in South Africa whose work centers on ischaemic heart disease and tuberculous pericardial disorders in high-burden settings. His scholarship reflects strong engagement with tertiary academic hospitals and multicentre collaborations, contributing to context-specific evidence for sub-Saharan Africa. He is recognized for advancing clinically relevant research that addresses gaps in care where access to advanced cardiac interventions is limited.

His publications highlight major focus areas in ST-segment elevation myocardial infarction, including in-hospital mortality, reperfusion strategies, and pragmatic trial design such as the RIC-AFRICA study. He has led and contributed to prospective cohorts and randomized trial protocols aimed at improving risk stratification and evaluating low-cost, scalable therapies. This work demonstrates expertise in clinical epidemiology, outcomes research, and translational cardiology tailored to resource-constrained environments.

A significant portion of his earlier work explores tuberculosis-related cardiac disease, including constrictive and tuberculous pericarditis, immunomodulatory therapies, and surgical outcomes in the HIV era. Through involvement in major trials and comprehensive reviews, he has helped clarify management strategies for inflammatory and infectious cardiac conditions. Collectively, his research bridges infectious disease and cardiology, with meaningful implications for policy and patient care across the region.